BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16027752)

  • 21. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally administered colistin leads to colistin-resistant intestinal flora and fails to prevent faecal colonisation with extended-spectrum β-lactamase-producing enterobacteria in hospitalised newborns.
    Strenger V; Gschliesser T; Grisold A; Zarfel G; Feierl G; Masoud L; Hoenigl M; Resch B; Müller W; Urlesberger B
    Int J Antimicrob Agents; 2011 Jan; 37(1):67-9. PubMed ID: 21074372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
    Nadkarni AS; Schliep T; Khan L; Zeana CB
    Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.
    Morosini MI; García-Castillo M; Coque TM; Valverde A; Novais A; Loza E; Baquero F; Cantón R
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2695-9. PubMed ID: 16870760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.
    Arpin C; Quentin C; Grobost F; Cambau E; Robert J; Dubois V; Coulange L; André C;
    J Antimicrob Chemother; 2009 Jun; 63(6):1205-14. PubMed ID: 19329798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended-spectrum beta-lactamases in long-term-care facilities.
    Nicolas-Chanoine MH; Jarlier V;
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():111-6. PubMed ID: 18154534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004).
    Goossens H; Grabein B
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):257-64. PubMed ID: 16360549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
    Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
    J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.
    Kola A; Holst M; Chaberny IF; Ziesing S; Suerbaum S; Gastmeier P
    J Hosp Infect; 2007 May; 66(1):46-51. PubMed ID: 17350720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
    Rodríguez-Baño J; Miró E; Villar M; Coelho A; Gozalo M; Borrell N; Bou G; Conejo MC; Pomar V; Aracil B; Larrosa N; Agüero J; Oliver A; Fernández A; Oteo J; Pascual A; Navarro F
    J Infect; 2012 Feb; 64(2):176-83. PubMed ID: 22138600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
    Lee CH; Su LH; Tang YF; Liu JW
    J Antimicrob Chemother; 2006 Nov; 58(5):1074-7. PubMed ID: 16971415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
    Giraud-Morin C; Fosse T
    Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
    Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
    J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
    Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
    J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First report of CTX-M-15 and CTX-M-3 beta-lactamases among clinical isolates of Enterobacteriaceae in Béjaia, Algeria.
    Touati A; Benallaoua S; Forte D; Madoux J; Brasme L; de Champs C
    Int J Antimicrob Agents; 2006 May; 27(5):397-402. PubMed ID: 16621456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B; Mathur P; Das A; Kapil A
    Singapore Med J; 2009 Jun; 50(6):628-32. PubMed ID: 19551319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.